Package 42794-012-08

Brand: griseofulvin

Generic: griseofulvin
NDC Package

Package Facts

Identity

Package NDC 42794-012-08
Digits Only 4279401208
Product NDC 42794-012
Description

30 TABLET in 1 BOTTLE (42794-012-08)

Marketing

Marketing Status
Marketed Since 2016-07-01
Brand griseofulvin
Generic griseofulvin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e8a91e6c-8bed-66f5-e053-2a95a90aa489", "openfda": {"nui": ["N0000008732", "N0000175085", "N0000175848"], "upc": ["0342794012082"], "unii": ["32HRV3E3D5"], "rxcui": ["310600"], "spl_set_id": ["5bafb97f-621b-4b96-a787-68e0bb5c8637"], "pharm_class_pe": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]"], "pharm_class_epc": ["Tubulin Inhibiting Agent [EPC]"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (42794-012-08)", "package_ndc": "42794-012-08", "marketing_start_date": "20160701"}], "brand_name": "Griseofulvin", "product_id": "42794-012_e8a91e6c-8bed-66f5-e053-2a95a90aa489", "dosage_form": "TABLET", "pharm_class": ["Decreased Mitosis [PE]", "Microtubule Inhibition [PE]", "Tubulin Inhibiting Agent [EPC]"], "product_ndc": "42794-012", "generic_name": "Griseofulvin", "labeler_name": "Sigmapharm Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Griseofulvin", "active_ingredients": [{"name": "GRISEOFULVIN", "strength": "500 mg/1"}], "application_number": "ANDA202482", "marketing_category": "ANDA", "marketing_start_date": "20121206", "listing_expiration_date": "20261231"}